Presentamos #APOLO, el nuevo Clúster de la Industria de Defensa de la Comunitat Valenciana, una iniciativa que reúne a empresas, centros tecnológicos y universidades para impulsar la innovación dual, la competitividad industrial y la autonomía tecnológica. Desde Quibim nos enorgullece formar parte de este proyecto estratégico que busca articular capacidades, generar nuevas oportunidades de colaboración y reforzar la posición de la Comunitat Valenciana como polo de referencia en tecnologías aplicadas a la defensa. La Junta Directiva del clúster está presidida por S2GRUPO, representada por su CEO, José Miguel Rosell Tejada, y cuenta con la participación de Fernando Gastaldo Lázaro, Director General de FACTOR Ingeniería y Decoletaje; Fernando Gómez, CEO B-libe; Javier Quilis, CEO de INELCOM, Ingeniería Electrónica Comercial; y Ángel Alberich-Bayarri, CEO de Quibim, reflejando la diversidad sectorial del proyecto en su fase inicial. La visión de APOLO es convertir a la Comunitat Valenciana en un referente nacional e internacional en investigación, innovación, diseño, fabricación y tecnología aplicada a la defensa, apoyándose en su base empresarial, su ecosistema innovador y su capacidad logística y de talento. #ClústerAPOLO #IndustriaDeDefensa #ComunitatValenciana
On #WorldCancerDay, we showcase Communications Medicine's insights into addressing a fundamental question in healthcare: how is innovation transforming the global fight against cancer? The article “𝘈𝘳𝘵𝘪𝘧𝘪𝘤𝘪𝘢𝘭 𝘐𝘯𝘵𝘦𝘭𝘭𝘪𝘨𝘦𝘯𝘤𝘦 𝘧𝘰𝘳 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵” highlights four key takeaways that may be applicable to other types of cancer, based on the latest evidence. • AI may help improve diagnostic accuracy in imaging and pathology. • Personalized treatment plans improve patient outcomes. • Smarter clinical decisions help reduce unnecessary interventions. • Challenges remain: adoption, regulation, and equitable access. Regardless of our role in healthcare, World Cancer Day reminds us that we must invest, collaborate, and innovate to achieve a future where cancer is not only treatable, but also more preventable. https://lnkd.in/enEKT5Cc Springer Nature #AIinHealthcare #PrecisionMedicine #CancerResearch #BreastCancer
Thank you to everyone who joined us at the BAUS North West Urology Meeting in Manchester. It was a pleasure to connect with the urology community and share how AI is advancing #ProstateCancer care pathways. If you didn't get a chance to meet us, we'd love to continue the conversation. Feel free to contact our team or request a demo: https://bit.ly/4bvwRbx Francesca Evans Maria Proud , MHA Sid Singh Adesina Adesuyi George Eliot Hospital NHS Trust #MedicalImaging #AIinHealthcare #Innovation #Urology
We look forward to connecting with the community at the 25th PMWC - Precision Medicine World Conference 2026, taking place March 4–6 in Santa Clara, California, co-hosted by Stanford University, University of California, San Francisco, and Yale University. On March 4, our CEO will lead the session “𝘈𝘐-𝘌𝘯𝘩𝘢𝘯𝘤𝘦𝘥 𝘐𝘮𝘢𝘨𝘪𝘯𝘨: 𝘙𝘢𝘥𝘪𝘰𝘮𝘪𝘤𝘴, 𝘙𝘢𝘥𝘪𝘰𝘨𝘦𝘯𝘰𝘮𝘪𝘤𝘴 & 𝘚𝘪𝘮𝘶𝘭𝘢𝘵𝘪𝘰𝘯”, exploring how Quibim’s technology is transforming decision-making in drug development and precision health. Don’t miss it! Tal Behar #PMWC26 #PrecisionMedicine #Biotech
À Punt Radiotelevisió Valenciana se hizo eco ayer, Día Internacional del Cáncer, de cómo la innovación con sello valenciano se está exportando al resto del mundo para mejorar la vida de los pacientes, impulsando la prevención y el diagnóstico temprano. Para Quibim es un orgullo formar parte de un ecosistema científico vibrante, con ambición internacional, pero con un fuerte compromiso local. 🗞️ Artículo completo: https://web.apunt.es/cfsYl #Cancer #InnovaciónEnSalud #IAEnMedicina
Quibim was present as an industry partner at the 8th Annual Practical Urology Conference in Los Angeles, organized by the USC Institute Of Urology, one of our newest partners. If you haven’t yet seen how QP-Prostate streamlines fusion biopsy and focal therapy with AI—bringing radiology and urology into closer alignment to improve #ProstateCancer outcomes—you can still book a demo: https://bit.ly/4bvwRbx #AIinHealthcare #Urology #Radiology #MedicalImaging #PrecisionMedicine
AI has the potential to greatly improve how we assess treatment response in oncology, but that potential can only be realized through collaborative efforts to rigorously validate new methods and proposed standards. We are proud to participate in the ai.RECIST working group led by Friends of Cancer Research, which promotes AI-based tumor assessments that are validated, interpretable, and ready for regulatory decision-making. As a contributing member, our tool that automatically detects, measures, and tracks lesions across timepoints will be evaluated in the planned study. 📄 This white paper outlines: ✔️ Limitations of current imaging-based endpoints and opportunities to advance beyond #RECIST ✔️ Emerging AI-driven approaches, including enhanced RECIST, radiomics, volumetric analysis, and growth kinetics ✔️ Key elements of a framework to validate novel AI-based imaging endpoints, including outstanding questions around endpoint definition and considerations for meta-analysis https://bit.ly/3MaUTy8 #AIinHealthcare #MedicalImaging #ClinicalTrials #CancerResearch #LifeSciences
This scoping review published in Cureus Journal of Medical Science analyzes the role of artificial intelligence in reducing error rates in radiology, highlighting how AI can help clinicians. As the volume and complexity of images increase, evidence-based analyses such as this one are essential to understanding where AI already adds value and how it can be responsibly expanded in real-world practice. Read the full article: https://lnkd.in/ergY6qZg #MedicalImaging #AIinHealthcare #Innovation
We start 2026 strong. Reinforcing our commitment to the Life Sciences sector, we’re proud to welcome Dr Jeanne Bolger, MB BCh BAO, as Independent Director and Advisor at Quibim. With decades of healthcare experience, Jeanne will support strategic collaborations with pharmaceutical leaders and help accelerate innovation across oncology, immunology, and neurology. Her appointment strengthens a Board that brings together leaders from global healthcare and investment, and marks an important milestone in our strategy to expand Quibim’s life sciences footprint worldwide. https://bit.ly/4rBpFzt #LifeSciences #Innovation #Oncology #Immunology #Neurology
🇬🇧 We will soon be attending the BAUS North West Urology Meeting in Manchester on 5–6 February. Don’t miss our session, “𝘛𝘩𝘦 𝘈𝘐-𝘌𝘯𝘢𝘣𝘭𝘦𝘥 𝘗𝘳𝘰𝘴𝘵𝘢𝘵𝘦 𝘊𝘢𝘯𝘤𝘦𝘳 𝘊𝘢𝘳𝘦 𝘗𝘢𝘵𝘩𝘸𝘢𝘺: 𝘊𝘶𝘳𝘳𝘦𝘯𝘵 𝘢𝘯𝘥 𝘍𝘶𝘵𝘶𝘳𝘦 𝘗𝘦𝘳𝘴𝘱𝘦𝘤𝘵𝘪𝘷𝘦𝘴,” delivered by Sid Singh and Adesina Adesuyi from the George Eliot Hospital NHS Trust. 5th of Feb at 3pm. As the urology community comes together to share innovation, education, and clinical excellence, we invite you to visit Maria Proud , MHA, Business Development Manager at Quibim and Francesca Evans, Clinical Applications Specialist - UK, or book a demo in advance here: https://lnkd.in/ec9Qt8pq. #MedicalImaging #AIinHealthcare #Innovation #ProstateCancer #Urology
